FDAsafety guidance72% confidence
Compounding Quality Center of Excellence | Instructor-Led Trainings
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as opioid treatment pharma companies.
Regulatory Analysis
The Compounding Quality Center of Excellence’s free in-person training programs target outsourcing facility staff and offer continuing education credits. The training will open for state regulators and pharmacy compounders if space is available.
Supporting Context
- Therapeutic area
- Addiction · Opioids
- Sub-indication
- Pain
Related signal: University of Missouri-Columbia Launches Naloxone Training Initiative to Combat Opioid Overdoses